January 12, 2017 / 10:27 PM / 8 months ago

BRIEF-Acasti Pharma Q3 loss C$0.22/shr

Jan 12 (Reuters) - Acasti Pharma Inc

* Acasti Pharma reports third quarter 2017 financial results

* Q3 loss per share C$0.22

* Acasti pharma - Had cash,short-term investments of $5.8 million as of Nov 30, 2016

* Acasti Pharma - if co doesn’t raise additional funds, there exists material uncertainty casting substantial doubt about ability to continue as going concern Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below